Funded Health Care Startups in San Francisco
Disclosed round sizes in this San Francisco health care set are concentrated in the tens of millions, except for a single outlier: House Rx’s $55M Series B…
Disclosed round sizes in this San Francisco health care set are concentrated in the tens of millions, except for a single outlier: House Rx’s $55M Series B on 2025-11-16. Several other large rounds sit close to that level ($43M Medallion on 2025-08-18; $44M Ellipsis Health on 2025-05-01; $40M Thatch on 2025-04-03; $40M Noctrix Health on 2024-01-16), while many earlier/adjacent financings cluster much lower (e.g., $2M Jaguar Health on 2025-05-21; $2M Shimmer on 2024-01-10).
The timing shows a tight recent window: 8 of the 50 rows have round dates from 2025-11-04 through 2025-11-25 (Intellihealth $5M on 2025-11-25; Ember Copilot $4M on 2025-11-23; House Rx $55M on 2025-11-16; Amae Health $25M on 2025-11-04). Stage labels are mixed but “Series Unknown” appears frequently (7 entries, including Intellihealth 2025-11-25 $5M; Medallion 2025-08-18 $43M; Avive Solutions 2024-02-01 $41M), and at least 4 financings are marked “undisclosed” (Voxela 2024-10-21; Endo Health 2024-06-25; Allermi 2024-04-01; plus one row with no stage label shown: Float Health $10M on 2024-03-28).
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the largest disclosed round in this San Francisco health care list, and how does it compare to the next tier of deals?
House Rx’s $55M Series B on 2025-11-16 is the only disclosed round above $50M in the 50 rows. The next-largest disclosed amounts are $43M (Medallion, 2025-08-18) and $44M (Ellipsis Health, 2025-05-01), which are substantially lower than the $55M peak.
Do deal sizes cluster in a particular band, or are there many small rounds alongside a few large ones?
Large financings concentrate in the tens of millions (e.g., August Health $29M on 2025-08-07; Amae Health $25M on 2025-11-04; Rhythm Diagnostic Systems $16M on 2025-10-01; Alchemy $31M on 2024-10-15). At the same time, several rounds land near the bottom of the disclosed range (e.g., $2M Jaguar Health on 2025-05-21; $2M Teal Health on 2024-10-17; $250K NeuroAge Therapeutics on 2024-03-07), indicating a wide dispersion rather than a single tight size band.
Is the most recent funding activity concentrated in a narrow time window?
Yes. Between 2025-11-04 and 2025-11-25, 8 of the 50 rows close: from Intellihealth ($5M, 2025-11-25) and Ember Copilot ($4M, 2025-11-23) to House Rx ($55M, 2025-11-16) and Amae Health ($25M, 2025-11-04). Outside that window, the list continues with additional large rounds (e.g., Medallion $43M on 2025-08-18) but less density than late November 2025.
What stage labeling pattern stands out, and how should it affect deal comparisons?
“Series Unknown” shows up in 7 entries (including Intellihealth $5M on 2025-11-25; Mecha Health $4M on 2025-11-06; Medallion $43M on 2025-08-18; Avive Solutions $41M on 2024-02-01). Separately, 4 entries are marked “undisclosed” (Voxela 2024-10-21; Endo Health 2024-06-25; Allermi 2024-04-01; plus the list includes one row with a blank stage field for Float Health $10M on 2024-03-28), so comparisons by disclosed stage/size will be incomplete for those rows.
Which entries look like sizing outliers at the low end (and what’s the smallest disclosed amount)?
The smallest disclosed amount in the 50 rows is $250K for NeuroAge Therapeutics on 2024-03-07. Several other very small disclosed rounds sit just above that floor (e.g., $500K rounds for Amby Health on 2025-03-12 and Docflow on 2024-12-04), while larger outliers on the high end include House Rx $55M (2025-11-16) and Sprinter Health $55M (2025-05-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.